HUE032665T2 - Fogíny alatti tasak fertõzések kezelése - Google Patents

Fogíny alatti tasak fertõzések kezelése Download PDF

Info

Publication number
HUE032665T2
HUE032665T2 HUE06808626A HUE06808626A HUE032665T2 HU E032665 T2 HUE032665 T2 HU E032665T2 HU E06808626 A HUE06808626 A HU E06808626A HU E06808626 A HUE06808626 A HU E06808626A HU E032665 T2 HUE032665 T2 HU E032665T2
Authority
HU
Hungary
Prior art keywords
alkalmazás
gingival
sub
infection
compound
Prior art date
Application number
HUE06808626A
Other languages
English (en)
Inventor
Gosta Rutger Persson
Original Assignee
Maelor Laboratories Ltd
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0523745.8A external-priority patent/GB0523745D0/en
Priority claimed from GB0600324A external-priority patent/GB0600324D0/en
Application filed by Maelor Laboratories Ltd, Merial Inc filed Critical Maelor Laboratories Ltd
Publication of HUE032665T2 publication Critical patent/HUE032665T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Claims (5)

  1. SSTABA»ALMI IGÉNYPONTOK 1-¾ P) áWiftós PsíStű moribuuvegyéku
    ahol Rí jelentése egyenes vagy elágazó láueú. A I 6 sgènatotnos aftôlâsô|sort δ modbliagyöm 2. vagy à, poddo-jában, és R?. jelentése egyenes vagy elágazó làrseù.
  2. 2-10 saémdoitms alkilospÄ. l8(ärbs8-s^>c«'Ugi msbs&amp;iiúálvs, kivétő sí alfa· pozícióba», vagy gyógyí.;íefé$.2etHa0-ali>pi^hat<s »éjt á8§gtpggá9&amp;:$$&amp;$Btt k>gi§y sliutlotaxsk fcsstalésére wigáló gyógyszer etóálliubáhan, ahol a fogUsv alatti tasak 4 pp mély vapaMlyébl::: % Â2; L tggpyptpi;. aasisM JkámatSÉk ulioia sppsiabmk összege s möÄöSff^öfet R? &amp; :Rä esaporffälbäts legalább Ul, előnyösen Hi és 20 köxbitk
  3. 3. A?. I. vagy 2. igénypont szerint) íslkaimaaás, ahol « morfolinvegyökt R* csoportja hkirosícsoponta} végződik.
  4. 4. A* biixd |psy|!»msA felrmelyikií sàë sikglmsxàs, iia möííe!mY«iyöM 3-{4«p»p!“hepö«4·^ Hidrozi-ePj-mofíbHn. A Αχ : előző I|glö|f|üo»t0^ alk»!ts&amp;z% Äi « tMSzótt -fogíny alatti tasak" áartalmaam a 'FamemÍiM βϊ?ψώ?!Μΐ$, Farphyrommœ gtng(wti8e Trtffîmm® ikmeote vagy äsmabädilKs iîgiiiîas^eéRaséeRîRôæ bármelyikéé.: b. Axéilxl igénypíitek bpselylke s^rlífkafelmö^s, íihol a fegmy ARI fértoxést löggyökéyh&amp;dyssggyuyaífás Jeiieméx, %Mz ei§a# i|#ypos^kfcérmö!ylk«: szerinti álkslmtíxás, ahol a íégmy álaRI felázást krön skws ÍbggyÖk#;yf|yav gyulladás jellemez. ». Αχ elôzb apaypögfcök bâ^«iyîke szefíatl áikálmaxás, ábö) a gyégyspfeáttaímaz további bakíéríaisellea«« szeri,
  5. 5. Αχ aidai àgépypoatôk báxmaiyiks szerinti alkalmazás, áböl $ ayOgysaer feialmaz mvábbé jypjládásgátlö sacra JO. Αχ előad (geaypaatökfeäi-sslyike : J4 . Aa előző igéstypoíiíöfc bármelyike szermil aikalawaa, ahal a gyógysfe ; szájé ix. Riprám, gél yäi|y piái formában va». J;&amp;. Részlet i|>gJ^:ÿla«i 4 fttftt mély vágy mélyebb, lévő gyulladás kezelésében történő alkalma zásra, amely ta^temaa ax i<4, lgéuypoab>k bármelyikében .$«ap«fár0S!:ó&amp;·-vágyóiétól- és utaslíáaokaL hogy a vegyRietst &amp; gyu lladás keze lésére kell : alkalmaiéi
HUE06808626A 2005-11-22 2006-11-22 Fogíny alatti tasak fertõzések kezelése HUE032665T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0523745.8A GB0523745D0 (en) 2005-11-22 2005-11-22 Method
GB0600324A GB0600324D0 (en) 2006-01-09 2006-01-09 Method

Publications (1)

Publication Number Publication Date
HUE032665T2 true HUE032665T2 (hu) 2017-10-30

Family

ID=37636121

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE06808626A HUE032665T2 (hu) 2005-11-22 2006-11-22 Fogíny alatti tasak fertõzések kezelése

Country Status (11)

Country Link
US (1) US20080287443A1 (hu)
EP (2) EP1951374B1 (hu)
JP (1) JP4994387B2 (hu)
CY (1) CY1118964T1 (hu)
DK (2) DK3184150T3 (hu)
ES (2) ES2625110T3 (hu)
HU (1) HUE032665T2 (hu)
LT (1) LT1951374T (hu)
PL (2) PL3184150T3 (hu)
PT (1) PT1951374T (hu)
WO (1) WO2007060413A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0502046D0 (en) 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
US20150010479A1 (en) * 2012-03-20 2015-01-08 Sinclair Pharmaceuticals Limited Treatment of microbial infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE439011B (sv) * 1980-03-21 1985-05-28 Ferrosan Ab Morfolinoforeningar, kompositioner innehallande dessa och anvendning derav
US4894221A (en) * 1981-03-19 1990-01-16 Ab Ferrosan Method of treating plaque using morpholine compounds
US4846200A (en) * 1983-01-17 1989-07-11 Wiley Larry J Periodontal pocket cleaner
WO1990014342A1 (en) 1989-05-24 1990-11-29 Pharmacia Ab Substituted isoxazolidines and isoxazolines
US5082653A (en) 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
US5147632A (en) * 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
ES2073776T3 (es) * 1990-11-09 1995-08-16 Pharmacia Ab Composiciones anti-placa mejoradas que comprenden una combinacion de morfolinoamino-alcohol y agente antimicrobiano.
US5755572A (en) * 1992-08-10 1998-05-26 Novadent Ltd. Oral hygiene irrigator syringe bulb
US5736175A (en) * 1996-02-28 1998-04-07 Nabisco Technology Co. Chewing gums containing plaque disrupting ingredients and method for preparing it

Also Published As

Publication number Publication date
EP3184150A1 (en) 2017-06-28
EP1951374A1 (en) 2008-08-06
EP1951374B1 (en) 2017-03-01
ES2744345T3 (es) 2020-02-24
US20080287443A1 (en) 2008-11-20
CY1118964T1 (el) 2018-01-10
DK1951374T3 (en) 2017-04-10
EP3184150B1 (en) 2019-06-19
PT1951374T (pt) 2017-06-08
JP4994387B2 (ja) 2012-08-08
PL3184150T3 (pl) 2020-03-31
LT1951374T (lt) 2017-05-10
DK3184150T3 (da) 2019-09-02
WO2007060413A1 (en) 2007-05-31
ES2625110T3 (es) 2017-07-18
JP2009516731A (ja) 2009-04-23
PL1951374T3 (pl) 2017-07-31

Similar Documents

Publication Publication Date Title
Drisko Nonsurgical periodontal therapy.
Mongardini et al. One stage full‐versus partial‐mouth disinfection in the treatment of chronic adult or generalized early‐onset periodontitis. I. Long‐term clinical observations
Pistorius et al. Efficacy of subgingival irrigation using herbal extracts on gingival inflammation
Teughels et al. One-stage, full-mouth disinfection: fiction or reality?
JPH06505745A (ja) 抗歯垢性を有する非抗細菌性テトラサイクリン組成物
Jorgensen et al. Responsible use of antimicrobials in periodontics
Sikka et al. Comparative anti-plaque and anti-gingivitis efficacy of two commercially available mouthwashes-4 weeks clinical study
DK1951374T3 (en) TREATMENT OF SUB-GINGIVAL POCHE INFECTIONS
Cleland Jr Opportunities and obstacles in veterinary dental drug delivery
Singh et al. Comparative evaluation between honey and chlorhexidine gluconate on the dental plaque levels and gingival health
Ower The Role of Self-Administered Plaque Control in the Management of Periodontal Diseases: 1. A Review of the Evidence
US20180085374A1 (en) Use of Morpholino Compounds for the Treatment of Halitosis
Manonmanipavithra et al. A review on chlorhexidine in periodontal therapy
Ciancio Chemotherapeutics in periodontics
Ahmad The Efficacy of Chlorhexidine Gel as an Adjunctive Treatment for Patient with Chronic Periodontitis.
Zabokova-Bilbilova et al. Clinical Study on the Effect of Chlorhexidine Mouth Rinse in Improving Oral Health in Orthodontic Patients with Fixed Appliances
CN103536680B (zh) 一种治疗牙周病的制剂
Dubey et al. Comaprison of efficacy of 0.2% chlorhexidine gluconate (hexy-mw) and herbal (hiora) mouth wash in controlling gingival and plaque index-a comparative study
Mendigeri et al. Clinical effects of different antiplaque agents on patients undergoing fixed orthodontic treatment-A comparative study
CN101312766A (zh) 龈下牙周袋感染的治疗
Sharma et al. Endodontic Management of Facial Cellulitis in relation to primary molars
Sjödin et al. Reduced Use of Antibiotics and Nasal Decongestants During Treatment with a Mouthwash Containing Delmopinol.
Hamed Non Surgical Treatment Of Chronic Periodontitis By Two Strategies Of Full Mouth Disinfection
Ramdurg et al. Clinical and Microbiological Effects of Chlorhexidine Mouth Wash, Chlorhexidine, Metronidazole and Combination Gel on Patients Undergoing Fixed Orthodontic Treatment-A Comparative Study
CN102614217A (zh) 一种治疗牙周病的制剂